Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Looking older on the outside might be linked to aging faster on the inside and can be affected by lifestyle choices and health risks.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

Physical activity, height, and smoking affect prostate cancer risk.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Dutasteride reduces DHT more effectively than finasteride.

Early balding at 40 increases prostate cancer risk.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Baldness may be linked to heart disease, but the evidence isn't strong enough to consider it a major risk factor.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires various treatments to prevent this.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires treatment to prevent malignancy.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Vertex pattern hair loss linked to higher prostate cancer risk.